Capromorelin Oral Solution

18 adverse event reports submitted to the FDA

Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.

Total Reports

Deaths Reported

2780.0%

Death Rate

Active Ingredients

Capromorelin Oral Solution

Administration Routes

OralUnknown

Species Affected

Dog 13

Cat 5

Most Affected Breeds

Retriever - Labrador 3

Domestic Shorthair 3

Domestic Longhair 2

Poodle (unspecified) 2

Maltese 2

Boxer (German Boxer) 1

Setter - Irish Red 1

Pointing Dog - German Short-haired 1

Crossbred Canine/dog 1

Dachshund - Miniature 1

Most Reported Reactions

Other abnormal test result NOS 6

Ataxia 6

Elevated alanine aminotransferase (ALT) 5

Abnormal ultrasound finding 5

Not eating 5

Elevated gamma-glutamyl transferase (GGT) 4

Death by euthanasia 4

Diarrhoea 4

Lethargy (see also Central nervous system depression in Neurological) 4

Inappetence 3

Dehydration 3

Jaundice 3

Outcome Breakdown

Recovered/Normal

7 (36.8%)

Outcome Unknown

4 (21.1%)

Euthanized

4 (21.1%)

Ongoing

3 (15.8%)

Died

1 (5.3%)

Source: FDA Center for Veterinary Medicine — Adverse Event Reports. Data reflects voluntary submissions and may not represent actual incidence rates.